The AVYIA Journal
All Articles · Page 7
The latest ketamine research explained in plain language, real patient case studies, and practical guides for your mental health.
Archive
Page 7 of 7
Ketamine Infusion for Obsessive-Compulsive Disorder.
Bloch MH. Ketamine Infusion for Obsessive-Compulsive Disorder. ClinicalTrials.gov. 2014 June; https://clinicaltrials.gov/study/NCT01349231 Highlights: In a placebo-controlled study...
Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder.
Highlights: Objective: To test the efficacy and safety of a single intravenous subanesthetic dose of ketamine...
Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
Ghasemi M, Kazemi MH, Yoosefi A, Ghasemi A, Paragomi P, Amini H, Afzali MH. Rapid...
Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression.
Shiroma, Johns et al. Augmentation of response and remission to serial intravenous subanesthetic ketamine in...
Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: Proof-of-concept.
Rodriguez, C. I., Kegeles, L. S., Levinson, A., Feng, T., Marcus, S. M., Vermes, D.,...
Transient resolution of treatment-resistant posttraumatic stress disorder following ketamine infusion.
D’Andrea, D., & Sewesll, R. A. (2013). Transient resolution of treatment-resistant posttraumatic stress disorder following...
Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.
Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, Iqbal S,...
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression.
Thomas D. Hull, Matteo Malgaroli, Adam Gazzaley, Teddy J. Akiki, Alok Madan, Leonardo Vando, Kristin...
At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-labeled effectiveness trial.
Thomas D. Hull, Matteo Malgaroli, Adam Gazzaley, Teddy J. Akiki, Alok Madan, Leonardo Vando, Kristin...
OnlineTalk to ProviderCall us